MacroGenics
MGNX
$4.34
Share price
-2.52%
Change (1 day)
-33.47%
Change (1 year)
Categories
MacroGenics (MGNX) - Total liabilities
Total liabilities on the balance sheet as of December 2023 : $0.14 B
According to MacroGenics's latest financial reports the company's total liabilities are $0.14 B. A company’s total liabilities is the sum of all current and non-current debts and obligations.
MacroGenics - Total liabilities on balance sheet (from 2012 to 2023)
Total liabilities by year
| Year | Total liabilities | Change |
|---|---|---|
| 2023-12-31 | $0.14 B | 5.31% |
| 2022-12-31 | $0.13 B | 44.79% |
| 2021-12-31 | $95.62 M | 15.41% |
| 2020-12-31 | $82.85 M | 1.2% |
| 2019-12-31 | $81.87 M | -8.27% |
| 2018-12-31 | $89.25 M | 19.57% |
| 2017-12-31 | $74.64 M | 75.59% |
| 2016-12-31 | $42.51 M | -7.45% |
| 2015-12-31 | $45.93 M | -12.68% |
| 2014-12-31 | $52.6 M | 12.23% |
| 2013-12-31 | $46.86 M | -24.39% |
| 2012-12-31 | $61.98 M | -22.68% |
| 2011-12-31 | $80.16 M |
Total liabilities for similar companies or competitors
| Company | Total liabilities | differencediff. | Country |
|---|---|---|---|
 Pfizer PFE | $137.21 B | 94,007.20% | 🇺🇸 USA |
 Eli Lilly LLY | $51.04 B | 34,909.84% | 🇺🇸 USA |
 Amgen AMGN | $90.92 B | 62,258.63% | 🇺🇸 USA |
 Gilead Sciences GILD | $39.37 B | 26,905.93% | 🇺🇸 USA |
 Merck MRK | $69.04 B | 47,250.91% | 🇺🇸 USA |
 Bristol-Myers Squibb BMY | $82.48 B | 56,470.76% | 🇺🇸 USA |
 Xencor XNCR | $0.28 B | 94.48% | 🇺🇸 USA |